Pharmaceutical compositions for treating osteoarthritis
US12285541B2 · kind B2 · utility
0Cited by
10References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 26, 2024 |
| Grant date | Apr 29, 2025 |
| Priority date | — |
| Expiry date | Jan 26, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/06
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present disclosure provides methods and compositions comprising hyaluronic acid (HA) hydrogel in combination with a saturated fatty acid for treating osteoarthritis. In some embodiments, aspects of the disclosure relate to pharmaceutical compositions comprising HA hydrogel in combination with a steroid. In some embodiments, the pharmaceutical compositions may be administrable via local, topical, and injection. In some embodiments, the pharmaceutical composition may be administrable by intra-articular injection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.